Long-term safety, tolerability, and efficacy of vismodegib in two patients with metastatic basal cell carcinoma and basal cell nevus syndrome

Tumor responses in advanced basal cell carcinoma (BCC) have been observed in clinical trials with vismodegib, a SMO antagonist. The result of SMO antagonism is inhibition Hedgehog Signaling Pathway (HHSP) downstream target genes. HHSP inhibition has been shown to affect stem cells responsible for bl...

Full description

Saved in:
Bibliographic Details
Main Authors: Glen J. Weiss (Author), Raoul Tibes (Author), Lisa Blaydorn (Author), Gayle Jameson (Author), Molly Downhour (Author), Erica White (Author), Ivor Caro (Author), Daniel D. Von Hoff (Author)
Format: Book
Published: PAGEPress Publications, 2011-12-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available